Table 1 Patient characteristics and baseline of two groups.
mNGS (n = 53) | CMT (n = 60) | P-value | |
|---|---|---|---|
Age (yr) | 58 (45, 68) | 57 (48, 64) | 0.6473 |
≥ 60, n (%) | 21 (40) | 22 (37) | 0.7467 |
< 60, n (%) | 32 (60) | 38 (63) | |
Gender | |||
Male, n (%) | 35 (66) | 37 (62) | 0.6296 |
Female, n (%) | 18 (34) | 23 (38) | |
BMI | 22.8 (21.2, 25.0) | 23.3 (21.6, 25.3) | 0.5539 |
APACHE II score before treatment | 26(23, 29.5) | 24(21,28.75) | 0.0362 |
SOFA score before treatment | 9.981 ± 2.839 | 8.983 ± 2.318 | 0.0422 |
VIS | 28 (19, 30) | 18 (10.5, 30) | 0.0174 |
Types of cardiac surgery | |||
Heart Valve Surgery | 29(55) | 35(58) | 0.6987 |
Coronary Artery Bypass Grafting | 16(30) | 20(33) | 0.7203 |
Aortic Surgery | 11(21) | 11(18) | 0.7456 |
Congenital Heart Defect Repair | 3(6) | 5(8) | 0.5804 |
Implantation of Assistive Devices | 3(6) | 0(0) | 0.0618 |
Heart Transplantation | 3(6) | 0(0) | 0.0618 |
Duration of surgery | 424.6 ± 150.6 | 409 ± 133.8 | 0.5627 |
CPB time | 199.0 (174.3, 296.0) | 192.5 (167.0, 291.3) | 0.4426 |
Aortic cross-clamp time | 116.0 (100.0, 159.5) | 110.0 (90.0, 142.5) | 0.4537 |
Laboratory examination before treatment† | |||
WBC (109/L) | 16.0 (12.9, 18.3) | 14.5 (8.6, 17.0) | 0.1377 |
Percentage of neutrophils (%) | 88.7 (85.0, 92.0) | 85.4 (80.0, 90.3) | 0.0173 |
PCT (ng/mL) | 9.1 (5.0, 23.1) | 10.2 (3.8, 17.7) | 0.6089 |
CRP (mg/L) | 157.7 (149.4, 173.9) | 152.6 (116.3, 162.3) | 0.0576 |
Scr (µmol/L) | 110.9 (95.20, 158.5) | 109.2 (85.80, 142.8) | 0.2812 |
ALT (U/L) | 45.0 (30.5, 117.5) | 39.5 (25.3, 96.0) | 0.2562 |
Lactate (mmol/L) | 4.3 (1.9, 8.4) | 3.7 (1.5, 7.5) | 0.3227 |
Ventilator parameters | |||
FiO2 (%) | 60 (50, 65) | 50 (40, 50) | 0.0003 |
PEEP | 9 (8, 10) | 8 (6, 8) | 0.0006 |
Oxygenation Index | 184.5 ± 39.5 | 206.0 ± 47.6 | 0.0108 |